Bayer share price falls as pharma giant’s results fail to cheer investors

German pharmaceutical giant Bayer released its third quarter 2024 earnings on Tuesday, reporting net sales of €10.0bn, down from €10.3bn in the same period last year.

The company’s share price dropped 12.12% on Tuesday afternoon, to €21.46.